2012 Mn Week Drugs

Front 1

First generation sulfonylureas

Back 1

- amide

Front 2

Thiazolidinediones

Back 2

- azone

Front 3

Glucocorticoid replacement

Back 3

- sone, solone

Front 4

Class - inhibits intestinal brush border absorption of starches and disaccharides

Back 4

a-glucosidase inhitbitors

Front 5

a-glucosidase inhitbitors

Back 5

Acarbose

Front 6

Glucocorticoid inhibitor, blocks conversion to pregnenolone

Back 6

Aminoglutethimide

Front 7

Rapid short acting insulin

Back 7

Aspart

Front 8

Used to treat cardiac symptoms associated with hyperthyroidism

Back 8

B-Adrenergic antiagonist

Front 9

Very potent corticosteroid

Back 9

Beclomethasone

Front 10

Class - insulin sensitizers, decrease blood glucose independent of functioning beta-cell

Back 10

Biguanides

Front 11

Treatment for PMO, inhibits resorption of bone

Back 11

Bisphosphonates (- dronate)

Front 12

Dopamine agonist

Back 12

Bromocriptine

Front 13

Dopamine agonist

Back 13

Cabergoline

Front 14

Synthetic Vita D for psoriasis

Back 14

Calcipotriene

Front 15

Most potent topical corticosteroid

Back 15

Clobetasol

Front 16

Central alpha blocker used for suppression test to diagnose pheochromocytoma

Back 16

Clonidine

Front 17

RANK-L inactivating Ab, (therefore inactivating osteoclasts)

Back 17

Denosumab

Front 18

Synthetic glucocorticoid used for suppression test for Cushing's diagnoses

Back 18

Dexamethasone

Front 19

Insulin that does not form microprecipitates, long acting,

Back 19

Ditemir

Front 20

Treatment for secondary hyperparathyroidism in patients with renal failure

Back 20

Doxercalciferol

Front 21

Hormone used to treat osteoporosis

Back 21

Estrogen (estradiol)

Front 22

GLP-1 mimetic

Back 22

Exenatide

Front 23

Optical only steroid

Back 23

Fluorometholone

Front 24

Insulin that forms microprecipitates, long acting, bioengineered

Back 24

Glargine

Front 25

Second generation sulfonylureas, once a day administration

Back 25

Glimepiride

Front 26

Second generation sulfonylureas

Back 26

Glyburide, Glipizide, Glimepiride

Front 27

Only IV administered insulin, short acting, crystalline zinc

Back 27

Human

Front 28

Glucocorticoid inhibitor, blocks conversion to pregnenolone, less side effects

Back 28

Ketoconazole

Front 29

T4 replacement

Back 29

Levothyroxine

Front 30

T3 replacement

Back 30

Liothyronine

Front 31

GLP-1 mimetic

Back 31

Liraglutide

Front 32

Rapid short acting insulin

Back 32

Lispro

Front 33

Class - Non-sulfonylurea secretagogues

Back 33

Meglitinides

Front 34

Biguanide, does not cause hypoglycemia

Back 34

Metformin

Front 35

Thiamide drug of choice

Back 35

Methimazole

Front 36

a-glucosidase inhitbitors

Back 36

Miglitol

Front 37

Adrenolytic used to treat Cushing's

Back 37

Mitotane

Front 38

Intermediate acting insulin

Back 38

NPH

Front 39

Medical treatment for acromegaly

Back 39

Octreotide

Front 40

Treatment for secondary hyperparathyroidism in patients with renal failure

Back 40

Paricalcitol

Front 41

Inhibits iodination of tyrosine and synthesis/release of thyroid hormone

Back 41

Potassium iodide

Front 42

Inhibits thyoid peroxidase and inhibits deiodonase

Back 42

Propylthiouracil (PTU)

Front 43

Given in small doses to increase bone formation

Back 43

PTH

Front 44

Selective estrogen receptor modifier, estrogenic effects in bone

Back 44

Raloxifene

Front 45

DPP-4 inhibitor, prevents degradation of GLP and GIP

Back 45

Sitagliptin

Front 46

Class - inhibits K+ channels to depolarization B cells, increasing insulin release

Back 46

Sulfonylureas

Front 47

Recombinant PTH

Back 47

Teriparatide

Front 48

Inhibits thyoid peroxidase

Back 48

Thiamides

Front 49

Class - enhance insulin target tissue sensitivity, PPARg gene transcription

Back 49

Thiazolidinediones

Front 50

Long acting insulin

Back 50

Ultralente